Home » Topics » Ocular, BioWorld Science

Ocular, BioWorld Science
RSS

International pivotal Trabio study completes enrollment

Jan. 14, 2004

ISV-205 limits IOP increase induced by corticosteroids

Jan. 9, 2004

InSite Vision completes sale of ISV-403 to Bausch & Lomb

Jan. 8, 2004

Approvable letter for Inspire's diquafosol tetrasodium ophthalmic solution

Dec. 30, 2003

Novel calpain inhibitor SNJ-1757 identified as anticataract agent with good corneal permeability

Dec. 23, 2003

Enrollment goal reached for phase III Xibrom trial

Dec. 22, 2003

Oxigene expands ophthalmology R&D program

Dec. 17, 2003

Inhibition of factor 5A1 reduces apoptosis caused by TNF-alpha

Dec. 16, 2003

National Eye Institute supports Genvec PEDF work through SBIR grants

Dec. 15, 2003

Allergan and Inspire sign copromotion agreement for Elestat

Dec. 11, 2003

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...